Lysyl Oxidase in Ectopic Cardiovascular Calcification: Role of Oxidative Stress
Antioxidants · 26.04.2024 · 13 (5) · 523
DOI: 10.3390/antiox13050523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 26.04.2024. Verfasst von Carme Ballester-Servera und 6 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones Biomédicas de Barcelona-Consejo Superior de Investigaciones Científicas (IIBB-CSIC), 08036 Barcelona, Spain. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III, Ministerio de Universidades.
Abstract (Originalsprache)
Lysyl oxidase (LOX)-mediated extracellular matrix crosslinking modulates calcification in atherosclerosis and aortic valve disease; however, this enzyme also induces oxidative stress. We addressed the contribution of LOX-dependent oxidative stress to cardiovascular calcification. LOX is upregulated in human-calcified atherosclerotic lesions and atheromas from atherosclerosis-challenged LOX transgenic mice (TgLOXVSMC) and colocalized with a marker of oxidative stress (8-oxo-deoxyguanosine) in vascular smooth muscle cells (VSMCs). Similarly, in calcific aortic valves, high LOX expression was detected in valvular interstitial cells (VICs) positive for 8-oxo-deoxyguanosine, while LOX and LOXL2 expression correlated with osteogenic markers (SPP1 and RUNX2) and NOX2. In human VICs, mito-TEMPO and TEMPOL attenuated the increase in superoxide anion levels and the mineralization induced by osteogenic media (OM). Likewise, in OM-exposed VICs, β-aminopropionitrile (a LOX inhibitor) ameliorated both oxidative stress and calcification. Gain- and loss-of-function approaches in VICs demonstrated that while LOX silencing negatively modulates oxidative stress and calcification induced by OM, lentiviral LOX overexpression exacerbated oxidative stress and VIC calcification, effects that were prevented by mito-TEMPO, TEMPOL, and β-aminopropionitrile. Our data indicate that LOX-induced oxidative stress participates in the procalcifying effects of LOX activity in ectopic cardiovascular calcification, and highlight the multifaceted role played by LOX isoenzymes in cardiovascular diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto de Investigaciones Biomédicas de Barcelona-Consejo Superior de Investigaciones Científicas (IIBB-CSIC), 08036 Barcelona, Spain.
- CIBER de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Institut de Recerca Sant Pau (IR SANT PAU), 08041 Barcelona, Spain.
- Instituto de Investigación Hospital La Paz, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
ORCID-Profile: Laia Cañes, Ana B García-Redondo, Cristina Rodríguez, José Martínez-González
Förderung
- Ministerio de Ciencia e Innovación
- Instituto de Salud Carlos III
- Ministerio de Universidades
Zitieren
APA
Ballester-Servera, C., Alonso, J., Cañes, L., Vázquez-Sufuentes, P., García-Redondo, A. B., Rodríguez, C., & Martínez-González, J. (2024). Lysyl Oxidase in Ectopic Cardiovascular Calcification: Role of Oxidative Stress. Antioxidants, 13(5), 523. https://doi.org/10.3390/antiox13050523
Vancouver
Ballester-Servera C, Alonso J, Cañes L, Vázquez-Sufuentes P, García-Redondo AB, Rodríguez C, et al. Lysyl Oxidase in Ectopic Cardiovascular Calcification: Role of Oxidative Stress. Antioxidants. 2024;13(5):523. doi:10.3390/antiox13050523
BibTeX
@article{BallesterServera2024,
author = {Ballester-Servera, Carme and Alonso, Judith and Cañes, Laia and Vázquez-Sufuentes, Paula and García-Redondo, Ana B and Rodríguez, Cristina and Martínez-González, José},
title = {Lysyl Oxidase in Ectopic Cardiovascular Calcification: Role of Oxidative Stress},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {5},
pages = {523},
doi = {10.3390/antiox13050523}
}
EUVIMED